Filing Details
- Accession Number:
- 0001708138-20-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-20 19:29:00
- Reporting Period:
- 2020-04-16
- Accepted Time:
- 2020-04-20 19:29:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-16 | 4,000 | $272.70 | 28,373 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-16 | 3,009 | $529.79 | 25,364 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-04-17 | 33 | $540.70 | 25,331 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 33 | $542.25 | 25,298 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 61 | $548.99 | 25,237 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 3 | $550.00 | 25,234 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 55 | $551.38 | 25,179 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 62 | $553.85 | 25,117 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 33 | $556.43 | 25,084 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 89 | $558.63 | 24,995 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 155 | $559.25 | 24,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 232 | $560.31 | 24,608 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 92 | $561.96 | 24,516 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 33 | $562.77 | 24,483 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 66 | $563.63 | 24,417 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-17 | 44 | $565.77 | 24,373 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-04-17 | 12,500 | $272.70 | 36,873 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-17 | 9,250 | $555.82 | 27,623 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-04-20 | 35 | $562.71 | 27,588 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 225 | $563.74 | 27,363 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 340 | $564.76 | 27,023 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 902 | $565.52 | 26,121 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 944 | $566.44 | 25,177 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 114 | $567.76 | 25,063 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 126 | $568.11 | 24,937 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 66 | $569.22 | 24,871 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 114 | $571.65 | 24,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 64 | $572.42 | 24,693 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 320 | $573.40 | 24,373 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-16 | 4,000 | $0.00 | 4,000 | $272.70 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-17 | 12,500 | $0.00 | 12,500 | $272.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 31,500 | 2023-09-09 | No | 4 | M | Direct | |
| 19,000 | 2023-09-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 200 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 89 shares of Company stock on April 17, 2020 at prices ranging from $558.61 to $558.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 155 shares of Company stock on April 17, 2020 at prices ranging from $559.21 to $559.39. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 232 shares of Company stock on April 17, 2020 at prices ranging from $560.02 to $560.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 92 shares of Company stock on April 17, 2020 at prices ranging from $561.92 to $561.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 66 shares of Company stock on April 17, 2020 at prices ranging from $563.39 to $563.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
- Represents volume-weighted average price of sales of 225 shares of Company stock on April 20, 2020 at prices ranging from $563.56 to $563.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
- Represents volume-weighted average price of sales of 340 shares of Company stock on April 20, 2020 at prices ranging from $564.14 to $564.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
- Represents volume-weighted average price of sales of 902 shares of Company stock on April 20, 2020 at prices ranging from $565.05 to $565.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
- Represents volume-weighted average price of sales of 944 shares of Company stock on April 20, 2020 at prices ranging from $566.01 to $566.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
- Represents volume-weighted average price of sales of 126 shares of Company stock on April 20, 2020 at prices ranging from $568.10 to $568.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
- Represents volume-weighted average price of sales of 66 shares of Company stock on April 20, 2020 at prices ranging from $569.10 to $569.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
- Represents volume-weighted average price of sales of 64 shares of Company stock on April 20, 2020 at prices ranging from $572.19 to $572.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
- Represents volume-weighted average price of sales of 320 shares of Company stock on April 20, 2020 at prices ranging from $573.01 to $573.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
